Vertex Historical Income Statement

VRTX Stock  USD 417.32  1.14  0.27%   
Historical analysis of Vertex Pharmaceuticals income statement accounts such as Total Revenue of 10.3 B, Gross Profit of 9 B, Other Operating Expenses of 6.4 B or Operating Income of 3.9 B can show how well Vertex Pharmaceuticals performed in making a profits. Evaluating Vertex Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Vertex Pharmaceuticals's future profits or losses.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Vertex Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vertex Pharmaceuticals is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.

About Vertex Income Statement Analysis

Vertex Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Vertex Pharmaceuticals shareholders. The income statement also shows Vertex investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Vertex Pharmaceuticals Income Statement Chart

Vertex Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Vertex's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Vertex Pharmaceuticals revenue and expense. Vertex Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Vertex Pharmaceuticals' Cost Of Revenue is fairly stable compared to the past year. Income Before Tax is likely to rise to about 4.6 B in 2024, whereas Interest Expense is likely to drop slightly above 28.9 M in 2024.

Total Revenue

Total revenue comprises all receipts Vertex Pharmaceuticals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Vertex Pharmaceuticals minus its cost of goods sold. It is profit before Vertex Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Vertex Pharmaceuticals. It is also known as Vertex Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Vertex Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Vertex Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.At this time, Vertex Pharmaceuticals' Cost Of Revenue is fairly stable compared to the past year. Income Before Tax is likely to rise to about 4.6 B in 2024, whereas Interest Expense is likely to drop slightly above 28.9 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit6.7B7.9B8.6B9.0B
Total Revenue7.6B8.9B9.8B10.3B

Vertex Pharmaceuticals income statement Correlations

1.00.980.970.970.970.970.960.640.451.00.980.630.970.050.970.450.96-0.040.140.650.610.660.790.94
1.00.980.970.980.980.970.950.640.450.990.980.630.960.060.970.450.96-0.040.140.640.620.650.780.94
0.980.980.920.920.921.00.910.590.440.980.930.641.00.110.990.550.93-0.020.090.70.570.70.820.91
0.970.970.920.980.980.90.960.670.440.961.00.650.890.020.90.310.96-0.150.20.560.630.570.710.93
0.970.980.920.981.00.90.950.660.430.960.980.540.89-0.040.90.330.940.030.170.570.650.580.720.93
0.970.980.920.981.00.90.950.660.480.960.980.560.89-0.030.910.340.950.030.210.570.650.590.720.93
0.970.971.00.90.90.90.90.580.440.970.910.631.00.130.980.580.91-0.010.080.70.560.710.820.9
0.960.950.910.960.950.950.90.460.490.950.970.650.89-0.060.910.330.99-0.120.20.590.420.590.740.89
0.640.640.590.670.660.660.580.460.30.620.670.480.580.140.560.160.46-0.070.130.450.990.520.530.67
0.450.450.440.440.430.480.440.490.30.460.490.580.410.170.520.340.5-0.020.810.350.280.310.410.44
1.00.990.980.960.960.960.970.950.620.460.970.660.970.030.970.450.96-0.070.140.670.60.680.810.94
0.980.980.931.00.980.980.910.970.670.490.970.70.9-0.010.920.320.96-0.150.210.620.640.630.770.94
0.630.630.640.650.540.560.630.650.480.580.660.70.630.050.640.180.66-0.610.310.690.40.70.750.63
0.970.961.00.890.890.891.00.890.580.410.970.90.630.120.970.550.9-0.010.050.710.560.710.830.9
0.050.060.110.02-0.04-0.030.13-0.060.140.170.03-0.010.050.120.130.460.0-0.20.26-0.140.1-0.2-0.150.06
0.970.970.990.90.90.910.980.910.560.520.970.920.640.970.130.640.93-0.020.160.680.540.680.810.88
0.450.450.550.310.330.340.580.330.160.340.450.320.180.550.460.640.420.170.110.30.160.310.360.33
0.960.960.930.960.940.950.910.990.460.50.960.960.660.90.00.930.42-0.130.220.590.420.580.730.89
-0.04-0.04-0.02-0.150.030.03-0.01-0.12-0.07-0.02-0.07-0.15-0.61-0.01-0.2-0.020.17-0.13-0.15-0.040.06-0.04-0.05-0.06
0.140.140.090.20.170.210.080.20.130.810.140.210.310.050.260.160.110.22-0.15-0.160.11-0.23-0.110.18
0.650.640.70.560.570.570.70.590.450.350.670.620.690.71-0.140.680.30.59-0.04-0.160.440.930.930.7
0.610.620.570.630.650.650.560.420.990.280.60.640.40.560.10.540.160.420.060.110.440.510.520.65
0.660.650.70.570.580.590.710.590.520.310.680.630.70.71-0.20.680.310.58-0.04-0.230.930.510.980.63
0.790.780.820.710.720.720.820.740.530.410.810.770.750.83-0.150.810.360.73-0.05-0.110.930.520.980.75
0.940.940.910.930.930.930.90.890.670.440.940.940.630.90.060.880.330.89-0.060.180.70.650.630.75
Click cells to compare fundamentals

Vertex Pharmaceuticals Account Relationship Matchups

Vertex Pharmaceuticals income statement Accounts

201920202021202220232024 (projected)
Total Revenue4.2B6.2B7.6B8.9B9.8B10.3B
Gross Profit3.6B5.5B6.7B7.9B8.6B9.0B
Other Operating Expenses3.0B3.3B4.8B4.6B6.1B6.4B
Operating Income1.2B2.9B2.8B4.3B3.8B3.9B
Ebit1.2B2.9B2.8B4.3B3.8B3.9B
Ebitda1.5B3.2B2.8B4.3B3.9B4.1B
Total Operating Expenses2.4B2.6B3.9B3.5B4.8B5.1B
Net Income1.2B2.7B2.3B3.3B3.6B3.8B
Income Tax Expense218.1M405.2M388.3M910.4M760.2M798.2M
Depreciation And Amortization260.3M331.8M6.7M37.8M181.3M190.4M
Cost Of Revenue547.8M736.3M904.2M1.1B1.3B1.3B
Income Before Tax1.4B3.1B2.7B4.2B4.4B4.6B
Total Other Income Expense Net197.4M260.5M(51.7M)(75M)629.6M661.1M
Research Development1.8B1.8B3.1B2.5B3.7B3.9B
Interest Expense58.5M58.2M61.5M54.8M44.1M28.9M
Selling General Administrative658.5M770.5M840.1M887.2M1.1B1.2B
Net Income From Continuing Ops1.2B2.7B2.3B3.3B3.6B3.8B
Non Operating Income Net Other255.9M318.7M9.8M(20.2M)(23.2M)(22.1M)
Net Income Applicable To Common Shares1.2B2.7B2.3B3.3B3.8B4.0B
Tax Provision218.1M405.2M388.3M910.4M760.2M798.2M
Interest Income63.7M22.2M4.9M144.6M614.7M645.4M
Net Interest Income5.2M(35.9M)(56.6M)89.8M570.6M599.1M
Reconciled Depreciation106.9M109.5M125.6M148.3M181.3M126.6M

Vertex Pharmaceuticals Investors Sentiment

The influence of Vertex Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Vertex. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Vertex Pharmaceuticals' public news can be used to forecast risks associated with an investment in Vertex. The trend in average sentiment can be used to explain how an investor holding Vertex can time the market purely based on public headlines and social activities around Vertex Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vertex Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vertex Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Vertex Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Vertex Pharmaceuticals.

Vertex Pharmaceuticals Implied Volatility

    
  26.38  
Vertex Pharmaceuticals' implied volatility exposes the market's sentiment of Vertex Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Vertex Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Vertex Pharmaceuticals stock will not fluctuate a lot when Vertex Pharmaceuticals' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vertex Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vertex Pharmaceuticals' short interest history, or implied volatility extrapolated from Vertex Pharmaceuticals options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.181
Earnings Share
13.89
Revenue Per Share
38.297
Quarterly Revenue Growth
0.093
Return On Assets
0.1317
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.